Rapid detection of SARS-CoV-2 antibodies in oral fluids
Preprint
Abstract
Current commercially available methods for reliably detecting antibodies against SARS-CoV-2 remain expensive and inaccessible due to the need for whole blood collection by highly trained phlebotomists using personal protective equipment (PPE). We evaluated an antibody detection approach utilizing the OraSure® Technologies’ Oral Antibody Collection Device (OACD) and their proprietary SARS-CoV-2 total antibody detection enzyme-linked immunosorbent assay (ELISA). We found that the OraSure® test for total antibody detection in oral fluid had comparable sensitivity and specificity to serum-based ELISAs while presenting a more affordable and accessible system with the potential for self-collection.Keywords
All Related Versions
- Published version: Journal of Clinical Microbiology, 59 (2).
This publication has 7 references indexed in Scilit:
- Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?Journal of Infection, 2020
- ELISA detection of SARS-CoV-2 antibodies in salivamedRxiv, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- The trinity of COVID-19: immunity, inflammation and interventionNature Reviews Immunology, 2020
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccineCellular & Molecular Immunology, 2020
- Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare WorkersmedRxiv, 2020
- The mucosal immune system: from fundamental concepts to vaccine developmentVaccine, 1992